Literature DB >> 22605841

Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80.

Iuliana Badiu1, Massimo Geuna, Enrico Heffler, Giovanni Rolla.   

Abstract

A 17-year-old girl reported generalised urticaria, eyelid angioedema, rhino-conjunctivitis, dyspnoea and wheezing 1 h after third intramuscular administration of quadrivalent human papilloma virus vaccine (Gardasil). She was treated with antihistamine, and corticosteroids with prompt relief of rhinitis and dyspnoea, while urticaria and angioedema lasted 24 h. Intradermal test with Gardasil, which contains polysorbate 80 (PS80), resulted positive, while skin tests with the bivalent vaccine were negative. Prick test performed with PS80 resulted positive in the patient and negative in ten healthy controls. The CD203 basophil activation test result was negative for PS80 at all the tested dilutions and specific IgE was not found. As flu vaccine was recommended, the authors skin tested two flu vaccine, one containing PS80 (Fluarix, GSK), which resulted positive and another flu vaccine with no adjuvant or preservative (Vaxigrip, Sanofi Pasteur MSD), which gave negative results. The patient then received Vaxigrip without adverse reactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605841      PMCID: PMC3351639          DOI: 10.1136/bcr.02.2012.5797

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Biologic-induced urticaria due to polysorbate 80: usefulness of prick test.

Authors:  L Pérez-Pérez; J García-Gavín; B Piñeiro; A Zulaica
Journal:  Br J Dermatol       Date:  2011-05       Impact factor: 9.302

2.  Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions.

Authors:  Esther A Coors; Heidi Seybold; Hans F Merk; Vera Mahler
Journal:  Ann Allergy Asthma Immunol       Date:  2005-12       Impact factor: 6.347

3.  Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy.

Authors:  Kursteen S Price; Robert G Hamilton
Journal:  Allergy Asthma Proc       Date:  2007 May-Jun       Impact factor: 2.587

4.  Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study.

Authors:  Liew Woei Kang; Nigel Crawford; Mimi L K Tang; Jim Buttery; Jenny Royle; Michael Gold; Christine Ziegler; Patrick Quinn; Sonja Elia; Sharon Choo
Journal:  BMJ       Date:  2008-12-02
  4 in total
  18 in total

1.  Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized.

Authors:  Cosby A Stone; Yiwei Liu; Mary V Relling; Matthew S Krantz; Amanda L Pratt; Andrew Abreo; Jonathan A Hemler; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-14

Review 2.  Immune-mediated adverse reactions to vaccines.

Authors:  Cosby A Stone; Christine R F Rukasin; Thomas M Beachkofsky; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2019-11-05       Impact factor: 4.335

3.  Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines.

Authors:  Mariko Mouri; Mitsuru Imamura; Shotaro Suzuki; Tatsuya Kawasaki; Yoshiki Ishizaki; Keiichi Sakurai; Hiroko Nagafuchi; Norihiro Matsumura; Marina Uchida; Takayasu Ando; Kohei Yoshioka; Seido Ooka; Takahiko Sugihara; Hiroshi Miyoshi; Masaaki Mori; Tomoyuki Okada; Masao Yamaguchi; Hiroyuki Kunishima; Motohiro Kato; Kimito Kawahata
Journal:  Allergol Int       Date:  2022-06-06       Impact factor: 7.478

Review 4.  Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.

Authors:  Maria Luisa Caballero; Matthew S Krantz; Santiago Quirce; Elizabeth J Phillips; Cosby A Stone
Journal:  J Allergy Clin Immunol Pract       Date:  2021-03-15

Review 5.  Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?

Authors:  Bernadette Eberlein; Sonja Mathes; Jörg Fischer; Ulf Darsow; Tilo Biedermann; Knut Brockow
Journal:  Allergy       Date:  2022-03-25       Impact factor: 14.710

Review 6.  COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee.

Authors:  Paul J Turner; Ignacio J Ansotegui; Dianne E Campbell; Victoria Cardona; Motohiro Ebisawa; Yehia El-Gamal; Stanley Fineman; Mario Geller; Alexei Gonzalez-Estrada; Paul A Greenberger; Agnes S Y Leung; Michael E Levin; Antonella Muraro; Mario Sánchez Borges; Gianenrico Senna; Luciana K Tanno; Bernard Yu-Hor Thong; Margitta Worm
Journal:  World Allergy Organ J       Date:  2021-02-03       Impact factor: 4.084

7.  COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.

Authors:  Aleena Banerji; Anna R Wolfson; Paige G Wickner; Amelia S Cogan; Aubree E McMahon; Rebecca Saff; Lacey B Robinson; Elizabeth Phillips; Kimberly G Blumenthal
Journal:  J Allergy Clin Immunol Pract       Date:  2021-04-15

8.  Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital.

Authors:  Giovanni Paoletti; Francesca Racca; Alessandra Piona; Giulio Melone; Morena Merigo; Francesca Puggioni; Sebastian Ferri; Elena Azzolini; Michele Lagioia; Donatella Lamacchia; Giuseppe Cataldo; Maurizio Cecconi; Giorgio Walter Canonica; Enrico Heffler
Journal:  World Allergy Organ J       Date:  2021-04-08       Impact factor: 4.084

Review 9.  Recent applications of basophil activation tests in the diagnosis of drug hypersensitivity.

Authors:  Woo-Jung Song; Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2013-10-31

10.  Biphasic anaphylaxis after first dose of mRNA COVID-19 vaccine with positive polysorbate 80 skin testing.

Authors:  Mitchell M Pitlick; Miguel A Park; Alexei Gonzalez-Estrada; Sergio E Chiarella
Journal:  Ann Allergy Asthma Immunol       Date:  2021-07-31       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.